Having been in this share since early 1999 and getting off after...

Having been in this share since early 1999 and getting off after PH2B results, I could not resist but get back in over the last couple of months. This is a classic MBP run and I suspect it shall hit $2 before announcment going on past history. Obesity is also back in the media a lot more which adds to the favourability of the stock. Generally most Aust. Biotechs are now moving off thier lows and off shore funds are starting to funnel into Aust. biotechs with some good Phase 2 results from our Biotechs.
Looks good timing for MBP if it comes off with the results.